METHODS FOR DETERMINING AND LIMITING THE POTENTIAL FOR DRUG-DRUG INTERACTIONS

摘要

The disclosure provides for methods that integrate metabolic ratio testing results from a patient's biological sample with the subject's pharmacogenomic makeup so as to determine the subject's risk for drug-drug interactions for co-administered drugs.